Authors:
YALCIN S
TEKUZMAN G
BALTALI E
OZISIK Y
BARISTA I
ZENGIN N
Citation: S. Yalcin et al., 5-HT3 RECEPTOR ANTAGONISTS IN PROPHYLAXIS OF ACUTE AND DELAYED EMESISINDUCED BY MODERATELY EMETOGENIC SINGLE DAY CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 718-718
Authors:
YALCIN S
KARS A
OZISIK Y
TEKUZMAN G
OZYILKAN O
CELIK I
BARISTA I
GULLU I
GULER N
BALTALI E
FIRAT D
Citation: S. Yalcin et al., VB-CHEP CHEMOTHERAPY REGIMEN FOR AGGRESSIVE NON-HODGKINS-LYMPHOMAS, European journal of haematology, 61(4), 1998, pp. 261-265
Authors:
KOC Y
AKPEK G
KANSU E
KARS A
TEKUZMAN G
BALTALI E
GULER N
BARISTA I
GULLU I
OZISIK Y
FIRAT D
Citation: Y. Koc et al., BOLUS AND CONTINUOUS-INFUSION MITOXANTRONE IN NEWLY-DIAGNOSED ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF 2 CONSECUTIVE PHASE-II CLINICAL-STUDIES, Cancer investigation, 16(6), 1998, pp. 355-365
Authors:
YALCIN S
GULLU I
BARISTA J
TEKUZMAN G
OZISIK Y
CELIK I
KARS A
Citation: S. Yalcin et al., TREATMENT OF ADVANCED REFRACTORY SARCOMAS WITH IFOSFAMIDE AND ETOPOSIDE COMBINATION CHEMOTHERAPY, Cancer investigation, 16(5), 1998, pp. 297-302
Authors:
ZENGIN N
KARS A
OZISIK Y
CANPINAR H
TURKER A
RUACAN S
Citation: N. Zengin et al., ALEUKEMIC LEUKEMIA-CUTIS IN A PATIENT WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Journal of the American Academy of Dermatology, 38(4), 1998, pp. 620-621
Authors:
KARS A
CELIK I
KANSU E
TEKUZMAN G
OZISIK Y
GULER N
BARISTA I
GULLU I
YALCIN S
ALTUNDAG K
ZENGIN N
TURKER A
HAYRAN M
BALTALT E
FIRAT D
Citation: A. Kars et al., MAINTENANCE THERAPY WITH ALPHA-INTERFERON FOLLOWING FIRST-LINE VAD INMULTIPLE-MYELOMA, European journal of haematology, 59(2), 1997, pp. 100-104
Authors:
BARISTA I
BALTALI E
GULLU IH
GULER N
CELIK I
SARACBASI O
TEKUZMAN G
KARS A
OZISIK Y
RUACAN S
ATAHAN IL
FIRAT D
Citation: I. Barista et al., FACTORS INFLUENCING THE DISTRIBUTION OF METASTASES AND SURVIVAL IN METASTATIC BREAST-CARCINOMA, American journal of clinical oncology, 19(6), 1996, pp. 569-573
Authors:
BAYRAKTAR Y
BALKANCI F
KAYHAN B
UZUNALIMOGLU B
GOKOZ A
OZISIK Y
GURAKAR A
VANTHIEL DH
FIRAT D
Citation: Y. Bayraktar et al., A COMPARISON OF CHEMOEMBOLIZATION WITH CONVENTIONAL CHEMOTHERAPY AND SYMPTOMATIC TREATMENT IN CIRRHOTIC-PATIENTS WITH HEPATOCELLULAR-CARCINOMA, Hepato-gastroenterology, 43(9), 1996, pp. 681-687
Authors:
KARS A
CELIK I
KANSU E
OZISIK Y
GULER N
BARISTA I
GULLU IH
YALCIN S
ALTUNDAG K
ZENGIN N
TEKUZMAN G
BALTALI E
FIRAT D
Citation: A. Kars et al., VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE CHEMOTHERAPY WITH OR WITHOUT INTERFERON-ALPHA-2B MAINTENANCE IN MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 3609-3609
Authors:
GULER N
BALTALI E
KARS A
OZISIK Y
ENUNLU T
TEKUZMAN G
OZYILKAN O
ONAT D
GULLU I
BARISTA I
FIRAT D
Citation: N. Guler et al., CMF OR CMF-IIIA BREAST-CARCINOMA(RT AS ADJUVANT THERAPY IN PATIENTS WITH STAGE I), European journal of cancer, 31A, 1995, pp. 70-70
Authors:
BARISTA I
TEKUZMAN G
GULLU I
BALTALI E
KARS A
OZISIK Y
GULER N
CELIK I
ATAHAN IL
FIRAT D
Citation: I. Barista et al., NON-HODGKINS-LYMPHOMAS OF THE TONSIL - A RETROSPECTIVE ANALYSIS OF 28PATIENTS WITH PRIMARY TONSILLARY LYMPHOMA, Tumori, 81(4), 1995, pp. 234-237
Authors:
BARISTA I
TEKUZMAN G
FIRAT D
BALTALI E
KANSU E
KARS A
OZISIK Y
RUACAN S
UZUNALIMOGLU B
KARAAGAOGLU E
Citation: I. Barista et al., NON-HODGKINS-LYMPHOMAS IN TURKEY - 18 YEARS EXPERIENCE AT THE HACETTEPE-UNIVERSITY, Japanese journal of cancer research, 85(12), 1994, pp. 1200-1207